Danaher/Abcam deal set to close next month; Cereno's loan; March Biosciences to advance its CAR-T into PhII
Danaher’s proposed acquisition of Abcam is expected to close Dec. 6: The companies announced the closing date on Friday. Danaher is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
